Full Text DE-92-03 PERIODONTAL DISEASES RESEARCH CENTERS NIH GUIDE, Volume 21, Number 12, March 27, 1992 RFA: DE-92-03 P.T. 04 Keywords: Periodontal Diseases Pathogenesis Etiology Epidemiology Diagnosis, Medical Disease Prevention+ National Institute of Dental Research Letter of Intent Receipt Date: August 17, 1992 Application Receipt Date: September 16, 1992 PURPOSE The National Institute of Dental Research (NIDR) invites applications for support of categorical Periodontal Diseases Research Centers to conduct multidisciplinary research on the etiology, epidemiology, prevention, risk assessment and diagnosis, pathogenesis, and treatment of the periodontal diseases. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This Request for Applications (RFA), Periodontal Diseases Research Centers, is related to the priority area of improving oral health. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0) or "Healthy People 2000" (Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238). ELIGIBILITY REQUIREMENTS Applications may be submitted by United States non-profit, public and private organizations, such as dental and medical schools, universities and research institutions. Applications from foreign institutions are not eligible. MECHANISM OF SUPPORT This RFA will use the National Institutes of Health specialized center grant (P50). Funding for the five existing NIDR-supported Periodontal Diseases Research Centers will terminate in Fiscal Year 1993. New awards will be made for five years, and the earliest funding date is August 1, 1993. This RFA is a one-time solicitation; issuance of a subsequent request for new and competing continuation applications is dependent on program needs and the availability of funds. Responsibility for the planning, direction, and execution of the proposed project will be solely that of the applicant institution; however, periodic consultation with NIDR staff will be expected. This may take the form of periodic site visits. FUNDS AVAILABLE The NIDR expects that $1 million in direct costs will be available to fund grants in response to this RFA. If a sufficient number of highly meritorious applications are received, it is anticipated that two or three awards will be made. Each award will not exceed $500,000 in direct costs for the first year. However, where indirect costs are assigned to a subcontract and counted as direct costs on the parent grant, the allowable direct cost may be exceeded by the amount of the indirect costs assigned to the subcontract. Increases in recurring costs for subsequent years will be limited to four percent. Award of grants pursuant to this RFA is contingent upon the receipt of funds. RESEARCH OBJECTIVES Background Periodontal diseases include a constellation of primarily inflammatory lesions initiated by microorganisms, which adversely affect the gingiva, periodontal connective tissues and alveolar bone. The associated destruction of periodontal supporting structures is one of the leading causes of tooth loss. Reports of the average prevalence of gingivitis range from forty to nearly 100 percent of the population. Studies of employed United States adults show that about 50 percent of 18-19 year old subjects exhibit at least one periodontal site with 2 mm or more attachment loss. Prevalence increases to about 80 percent at 35-39 years of age, and exceeds 90 percent for those over 60 years old. Prevalence and severity of the various periodontal diseases appear to be substantially greater in certain populations, particularly disadvantaged groups and medically-compromised patients. Most of the early-onset and rapidly progressive forms of periodontitis have been associated with systemic disturbances and periodontal lesions are reported as being more frequent and severe in patients with diabetes, neutrophil abnormalities, and some immunodeficiency disorders. There is considerable evidence that the periodontal diseases are initiated by microorganisms that colonize the teeth and adjacent periodontal tissues. Significant progress has been made in defining the oral microflora and in describing microbial subsets with pathogenic potential. Moreover, a substantial body of knowledge has evolved to explain mechanisms of periodontal tissue destruction and to provide strategies for restoration and maintenance of periodontal health. The NIDR encourages the submission of center grant applications that combine these research findings with new, innovative and multidisciplinary research, which will make fundamental contributions to eliminating periodontal diseases as causes of tooth loss. Goals of the Centers The primary goal of the Periodontal Diseases Research Centers program is to support multidisciplinary basic and clinical research leading to the prevention and control of the periodontal diseases. The following research areas are given as examples that may be particularly appropriate for inclusion in the application for support. However, no priorities are implied and the examples should not constrain applicants from proposing other research topics or investigative approaches. o Apply molecular methods for increasing our understanding of soft and hard tissue destruction resulting from the periodontal diseases, elucidate the fundamental mechanisms involved in normal metabolism, pathogenic destruction and repair of the periodontal tissues, and employ these new methods to further describe the natural history of the disease process. o Further describe the epidemiology, characteristics and progression of periodontal diseases in specific populations, including, but not limited to, medically compromised patients, women, racial and ethnic minorities, children, older adults and individuals with limited access to health care services. o Evaluate the relative efficacy of molecular (salivary, genetic), behavioral, social or other markers in predicting the risk of periodontal diseases for individual patients. o Develop and test new diagnostic methodologies that can be employed clinically to detect the onset and progression of periodontal diseases. o Investigate the potential of vaccines and other preventive strategies to deter specific bacterial colonization of tooth and mucosal surfaces. o Improve existing therapeutic methods and their delivery, with an emphasis on periodontal repair and regeneration. Center Characteristics Each research center will be an identifiable unit within a larger institution, already committed to some aspects of research relevant to the biology of the periodontium in health and disease. The center will consist of a cluster of interrelated projects, some of which may be fundamental and others may involve epidemiological, clinical, or behavioral studies. Some funds may be used to support pilot projects. These various projects should not constitute a collection of individual, unrelated investigations more appropriately supported by individual research project or small grants. Core resources such as animal facilities, computer services, and equipment to be shared by investigators will be provided, although budgetary constraints preclude expenditures for very expensive items of equipment or major renovations. The center director will provide strong and effective scientific and administrative leadership. The director will be responsible for maintaining high quality research, ensuring effective collaboration among individual investigators and communicating with NIDR staff. The director will be assisted by an advisory committee of consultants that includes members who are not associated with the applicant institution. It is expected that this advisory committee would have been consulted during preparation of the application and will advise the director on the merits and progress of present and future research projects. STUDY POPULATIONS SPECIAL INSTRUCTIONS TO APPLICANTS REGARDING IMPLEMENTATION OF NIH POLICIES CONCERNING INCLUSION OF WOMEN AND MINORITIES IN CLINICAL RESEARCH STUDY POPULATIONS NIH policy is that applicants for NIH clinical research grants will be required to include minorities and women in study populations so that research findings can be of benefit to all persons at risk of the disease, disorder or condition under study; special emphasis should be placed on the need for inclusion of minorities and women in studies of diseases, disorders and conditions which disproportionately affect them. This policy is intended to apply to males and females of all ages. If women or minorities are excluded or inadequately represented in clinical research, particularly in proposed population-based studies, a clear compelling rationale should be provided. The composition of the proposed study population must be described in terms of gender and racial/ethnic group. In addition, gender and racial/ethnic issues should be addressed in developing a research design and sample size appropriate for the scientific objectives of the study. This information should be included in form PHS 398 (rev. 9/91) in items 1-4 of the Research Plan and summarized in item 5, Human Subjects. Applicants are urged to carefully assess the feasibility of including the broadest possible representation of minority groups. However, NIH recognizes that it may not be feasible or appropriate in all research projects to include representation of the full array of United States racial, ethnic minority populations. The rationale for studies on single minority population groups should be provided. For the purpose of this policy, clinical research includes human biomedical and behavioral studies of etiology, epidemiology, prevention (and preventive strategies), diagnosis, or treatment of diseases, disorders or conditions, including but not limited to clinical trials. The usual NIH policies concerning research on human subjects also apply. Basic research or clinical studies in which human tissues cannot be identified or linked to individuals are excluded. However, every effort should be made to include human tissues from women and racial/ethnic minorities when it is important to apply the results of the study broadly, and this should be addressed by applicants. If the required information is not contained within the application, the application will be returned. Peer reviewers will address specifically whether the research plan in the application conforms to these policies. If the representation of women or minorities in a study design is inadequate to answer the scientific question(s) addressed AND the justification for the selected study population is inadequate, it will be considered a scientific weakness or deficiency in the study design and will be reflected in assigning the priority score to the application. All applications for clinical research submitted to the NIH are required to address these policies. NIH funding components will not award grants or cooperative agreements that do not comply with these policies. LETTER OF INTENT Prospective applicants are asked to submit, by August 17, 1992, a letter of intent that includes a descriptive title of the proposed center, the name, address and telephone number of the center director, the identities of other key personnel, and the number and title of this RFA. Although a letter of intent is not required, is not binding, and does not enter into the review of subsequent applications, the information that it contains is helpful in planning for the review of applications. It allows NIDR staff to estimate the potential review workload and to avoid possible conflict of interest in the review. The letter of intent is to be addressed to: Matthew Kinnard, Ph.D. Acting Director, Periodontal Diseases Program Extramural Program National Institute of Dental Research 5333 Westbard Avenue Westwood Building, Room 509 Bethesda, MD 20892 Telephone: (301) 496-7784 APPLICATION PROCEDURES Prospective applicants are advised to communicate with program and grants management staff of the NIDR Extramural Program as early as possible in the planning phase of application preparation. NIDR staff are available to assist applicants to ensure that the objectives, structure, and the budget format for the proposed center are acceptable. The research grant application form PHS 398 (rev. 9/91) is to be used in applying for these grants. These forms are available at most institutional business offices; from the Office of Grants Inquiries, Division of Research Grants, National Institutes of Health, 5333 Westbard Avenue, Room 449, Bethesda, MD 20892; and from the program administrator named above. The RFA label available in the form PHS 398 must be affixed to the bottom of the face page of the original application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, the RFA title and number must be typed in item 2a of the face page of the application form and the YES box checked. The instructions accompanying form PHS 398 must be followed as far as possible, but some modification will be necessary. For example, a new Table of Contents must be prepared giving page numbers for all items in the application. Pagination must be consecutive throughout the application. Each research and pilot project and core must be identified by number and investigator. A consolidated budget for the complete center for the entire project period must be presented (see page 5, form PHS 398). Separately detailed, annual and total budgets for the entire project period for each research project and core must be presented (use pages 4-5, form PHS 398). Direct and indirect costs are to be given. Funds may be requested for professional, technical, and administrative personnel; consultant services; equipment; supplies; travel; patient costs directly related to the research; minor renovations; and other costs. Detailed justification of the budget requests is required. Provide a summary of financial support from non-NIDR sources for studies that will complement and expand the program supported by the NIDR. Explain how these studies will further the goals of the center and make it more cost effective. Under Research Plan, describe the goals of the center and discuss the background and significance of the topics being addressed. Explain how each research and pilot project and the cores will contribute to achieving those goals. Describe the organizational and administrative structure, the responsibilities of the director and individual investigators, and the proposed mechanisms for monitoring scientific progress. Describe the relationship of all existing and pending institutional research projects that may be relevant to the center, regardless of funding source. Each research project must be presented as in a research project grant application, that is, the instruction pages 19-24 of form PHS 398 must be followed. Each project must be described within the 25-page limitation that applies to research project grant applications. Each pilot project must be presented in 400 words or less. Describe the cores and explain how they will relate to the projects that will utilize their resources. Abstracts (page 2, form PHS 398) must be completed for the entire application, each research project, the combined pilot research projects, and the combined cores. Submit a signed, typewritten original of the application, including the Checklist, and three signed, exact photocopies, in one package to: DIVISION OF RESEARCH GRANTS National Institutes of Health Westwood Building, Room 240 Bethesda, MD 20892 At the time of submission, two additional copies also must be sent to: Dr. George Hausch Chief, Scientific Review Office Extramural Program National Institute of Dental Research Westwood Building, Room 519 5333 Westbard Avenue Bethesda, MD 20892 Applications must be received by September 16, 1992. If an application is received after that date, it will be returned to the applicant. REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed by NIDR staff for completeness and responsiveness. Applications that are incomplete, nonresponsive to this RFA, or exceed the first year budget limit of $500,000 in direct costs will be returned to the applicant without further consideration. However, whenever indirect costs are assigned to a subcontract and counted as direct costs on the parent grant, the allowable direct cost maximum may be exceeded by the amount of the indirect costs assigned to the subcontract. Waivers of the receipt date deadline and budget limitation will not be granted. Those applications that are complete and responsive will be evaluated in accordance with the criteria stated below for scientific and technical merit by a special review committee convened by the NIDR Scientific Review Office. Applications may be subjected to triage by the review committee to determine the scientific merit relative to other applications received in response to this RFA. The NIDR will withdraw from further competition those applications judged by triage to be noncompetitive for award and notify the applicant and institutional official. Applications judged to be competitive will undergo further scientific merit review. This review may involve an applicant interview or site visit. The second level of review will be provided by the National Advisory Dental Research Council. Major factors to be considered in the evaluation of applications include: o The extent to which the center will promote advances in knowledge of the biology of the periodontium and of the etiology, epidemiology, risk factors and diagnosis, prevention, pathogenesis, and treatment of the periodontal diseases, that could not be achieved or that would be achieved more slowly if the component projects were funded separately. o The extent to which the various research and pilot projects and the cores have been combined into an effective and cohesive program and the adequacy of plans to ensure efficient collaboration, interaction, and dissemination of information among investigators. o The scientific and administrative qualifications, experience and commitment of the center director and his/her ability to provide effective leadership. Provisions for replacement of the director if it becomes necessary. o The competence of the center investigators and their commitment to accomplishing the proposed research goals. o The scientific merit of each proposed project, including its significance, originality, feasibility, experimental design, and methods, including those for data management and analysis. o The institutional environment, including its commitment to the proposed center, and to multidisciplinary, collaborative research of the highest quality. o The adequacy of laboratory, clinical, and animal facilities to meet the needs of the proposed studies. o The plans for establishing and developing the center, for monitoring research, for reviewing changes in research directions, and for the use of scientific advisory processes. o The availability and appropriateness of study populations and the utilization of women and minorities as study subjects. o The technical merit and justification for core resources requested and the appropriateness of the budget for each component project. o The appropriateness of the budget and period of support for research and pilot projects, cores, and for the entire center. o For competitive renewal applications, the extent to which the goals and specific aims of the previous application have been achieved. The inclusion of projects that are deemed to have little or no scientific merit or that are deemed peripheral to the center's objectives may be considered a reflection of the director's judgement and may adversely affect the rating. Component projects without significant and substantial merit will not be recommended for further consideration. If such projects are not deemed essential to the success of the center, they will be recommended for deletion. AWARD CRITERIA Awards will be made on the basis of the abailability of funds with consideration being given to program balance and also from results obtained through the NIH peer review mechanism. In addition the NIDR appreciates the value of complementary funding from other public and private sources, including foundations and industrial concerns, for activities that will complement and expand those supported by the NIDR. Such support will be considered in making any award. INQUIRIES Written and telephone inquiries concerning this RFA are encouraged. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to Dr. Matthew Kinnard at the address under LETTER OF INTENT. Direct inquiries concerning fiscal matters to: Theresa Ringler Grants Management Officer Extramural Program National Institute of Dental Research Westwood Building, Room 518 5333 Westbard Avenue Bethesda, MD 20892 Telephone: (301) 496-7437 AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.121. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-410, as amended by Public Law 99- 158, 42 USC 241 and 285) and administered under PHS grants policies and Federal Regulations 42 CFR 52 and 45 CFR Part 74. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |